Novel multiple apoptotic mechanism of shikonin in human glioma cells

Annals of Surgical Oncology

Volumn 19, Issue 9, 2012, Pages 3097-3106

  Chen, Ching Hsein ^a   Lin, Miao Ling ^a   Ong, Ping Lin ^a   Yang, Jen Tsung ^b  

^a NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOSPORIN A; GLUTATHIONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PIFITHRIN ALPHA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SHIKONIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; FLOW CYTOMETRY; GLIOMA CELL; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ACETYLCYSTEINE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BENZOTHIAZOLES; CATALASE; CELL LINE, TUMOR; CYCLOSPORINE; G1 PHASE CELL CYCLE CHECKPOINTS; GLIOMA; GLUTATHIONE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NAPHTHOQUINONES; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84867400770     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2324-4     Document Type: Article

References (23)

1. Mamelak AN, Jacoby DB. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv. 2007;4:175-86.
2. Persson AI, Weiss WA. The side story of stem-like glioma cells. Cell Stem Cell. 2009;4:191-2.
3. Wong ET, Brem S. Taming glioblastoma: targeting angiogenesis. J Clin Oncol. 2007;25:4705-6.
4. Cho MH, Paik YS, Hahn TR. Physical stability of shikonin derivatives from the roots of Lithospermum erythrorhizon cultivated in Korea. J Agric Food Chem. 1999;47:4117-20.
5. Han J, Weng X, Bi K. Antioxidants from a Chinese medicinal herb-Lithospermum erythrorhizon. Food Chem. 2008;106:2-10.
6. Chen CH, Chern CL, Lin CC, et al. Involvement of reactive oxygen species, but not mitochondrial permeability transition in the apoptotic induction of human SK-Hep-1 hepatoma cells by shikonin. Planta Med. 2003;69:1119-24.
7. Mao X, Yu CR, Li WH, Li WX. Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Ablpositive chronic myelogenous leukemia (CML) cells. Cell Res. 2008;18:879-88.
8. Yeh CC, Kuo HM, Li TM, et al. Shikonin-induced apoptosis involves caspase-3 activity in a human bladder cancer cell line (T24). In Vivo. 2007;21:1011-9.
9. Min R, Tong J, Wenjun Y, et al. Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca-8113 cell lines by Shikonin was partly through the inactivation of NFkappaB pathway. Phytother Res. 2008;22:407-15.
10. Hou Y, Guo T, Wu C, He X, Zhao M. Effect of shikonin on human breast cancer cells proliferation and apoptosis in vitro. Yakugaku Zasshi. 2006;126:1383-6.
11. Hsu PC, Huang YT, Tsai ML, Wang YJ, Lin JK, Pan MH. Induction of apoptosis by shikonin through coordinative modulation of the Bcl-2 family, p27, and p53, release of cytochrome c, and sequential activation of caspases in human colorectal carcinoma cells. J Agric Food Chem. 2004;52:6330-7.
12. Wu Z, Wu LJ, Li LH, Tashiro S, Onodera S, Ikejima T. Shikonin regulates HeLa cell death via caspase-3 activation and blockage of DNA synthesis. J Asian Nat Prod Res. 2004;6:155-66.
13. Wu Z, Wu L, Li L, Tashiro S, Onodera S, Ikejima T. p53-Mediated cell cycle arrest and apoptosis induced by shikonin via a caspase-9-dependent mechanism in human malignant melanoma A375-S2 cells. J Pharmacol Sci. 2004;94:166-76.
14. Lucke JF. Student's t test and the Glasgow Coma Scale. Ann Emerg Med. 1996;28:408-13.
15. Lee I, Bender E, Kadenbach B. Control of mitochondrial membrane potential and ROS formation by reversible phosphorylation of cytochrome c oxidase. Mol Cell Biochem. 2002;234/235:63-70.
16. Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994;9:1799-805.
17. Mihara M, Erster S, Zaika A, et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell. 2003;11:577-90.
18. Moll UM, Wolff S, Speidel D, Deppert W. Transcription independent pro-apoptotic functions of p53. Curr Opin Cell Biol. 2005;17:631-6.
19. Bragado P, Armesilla A, Silva A, Porras A. Apoptosis by cisplatin requires p53 mediated p38a MAPK activation through ROS generation. Apoptosis. 2007;12:1733-42.
20. Chipuk JE, Kuwana T, Bouchier-Hayes L, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 2004;303:1010-24.
21. Pollack IF, Finkelstein SD, Woods J, et al. Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med. 2002;346:420-7.
22. Hermisson M, Klumpp A, Wick W, et al. O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells. J Neurochem. 2006;96:766-76.
23. Guo XP, Zhang XY, Zhang SD. Clinical trial on the effects of shikonin mixture on later stage lung cancer. Zhong Xi Yi Jie He Za Zhi. 1991;11:598-9.